AzTrials
AzTrials

Physical FrailtyMINDEDNCT02082171

Multidomain Intervention to Prevent Disability in Elders

A study testing Multidomain intervention in people with Physical Frailty and Physical Disability, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Prevention of physical disability represents a major priority for the public health system. Physical disability is the final result of a complex cascade of negative events occurring at different levels (i.e., environmental, social, biological, and clinical). Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
Multidomain intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
210 participants
Where
1 siteFrance
Study dates
16 Oct 2013to 27 Jan 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age of 60 years and older;
  • Willingness to be randomized to either treatment group;
  • Pre-frailty or frailty status according to the phenotype described by Fried and colleagues

Who cannot join

  • Failure to provide informed consent;
  • Inability to complete a 400-meter walk test (primary outcome of the study);
  • Living in nursing home;
  • Living outside of the area of interest, or planning to move out of the area in next 3 years, or planning to leave the area for more than 3 months during the next year;
  • Relevant cognitive impairment (defined as a known diagnosis of dementia);
  • Severe progressive, degenerative neurologic disease (e.g., multiple sclerosis);
Show all 11Show fewer
  • Severe rheumatologic or orthopaedic diseases (e.g., awaiting joint replacement);
  • Terminal illness with life expectancy less than 12 months;
  • Severe pulmonary disease (e.g., oxygen therapy or chronic use of steroids);
  • Severe cardiac disease (e.g., New York Heart Association Class III or IV heart failure, clinically significant aortic stenosis, history of cardiac arrest, uncontrolled angina);
  • Other significant comorbid conditions that would impair the ability to participate in the multidomain intervention (e.g., renal failure on hemodialysis, severe psychiatric disorder, excessive alcohol use). To be noted: persons with depression will not be excluded.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre de Rééducation Fonctionnelle "La Roseraie"

    Montfaucon, 46240

Other trials in France

About this study

Prevention of physical disability represents a major priority for the public health system. Physical disability is the final result of a complex cascade of negative events occurring at different levels (i.e., environmental, social, biological, and clinical). The heterogeneity of the underlying mechanisms responsible for the onset of physical disability may require the adoption of preventive interventions affecting multiple domains. Although several studies suggest that single or different combinations of preventive interventions (in particular, physical activity, cognitive training, and healthy diet) might provide beneficial effects in preventing functional loss (and its related features, such as pain or reduced quality of life), very limited evidence coming from clinical trials is currently available on the topic. Intervention trials are usually designed to test the effect of a specific monodimensional intervention on a very selected population, so to reduce the risk of biased results. This approach, although legitimate and methodologically correct, may 1) be insufficient to target the multiple and heterogeneous physiopathological mechanisms underlying the onset of physical disability, and 2) cause a population selection bias leading to difficulties in implementing the study results to the overall older population (thus, determining the "evidence-based medicine" issue in the elderly). To our knowledge, there are no available data from clinical trials evaluating the effects of a multidomain intervention based on lifestyle modifications (e.g., physical activity, cognitive training, nutritional modification) for preventing mobility disability (a very early phase of the disabling process) in community-dwelling older persons. In the present project (Multidomain Intervention to preveNt Disability in ElDers, MINDED), we propose to conduct a pilot study aimed at estimating the effects of a multidomain person-tailored preventive intervention (based on physical activity, cognitive training, and nutritional modifications) on frailty status, physical performance, cognitive function, nutritional status, health-related quality of life, and use of health care services. In addition, we will perform cost-effectiveness analyses of the proposed intervention. The project will yield the necessary preliminary data to design a definitive full-scale Phase 3 randomized clinical trial. By providing a conclusive answer about the effectiveness of a multidimensional preventive program in the primary prevention of major health-related outcomes, the results of the full-scale trial will have relevant clinical and public health implications, and will promote the practicing of a truly evidence-based geriatric medicine.

Being tested
Multidomain intervention
Keywords
older adults, physical disability, multidomain intervention, prevention, pilot study, frailty, mobility, comprehensive geriatric assessment
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multidomain interventionOther

    Multidomain preventive intervention designed by a multidisciplinary team on the basis of results of a comprehensive geriatric assessment

Study groups in NCT02082171
Study groupRoleWhat they receive
Control groupNo interventionNot described
Intervention groupExperimentalComprehensive geriatric assessment followed by multi-domain preventive intervention
Receives: Other: Multidomain intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 400-meter walk test

    Incident inability to complete the 400-meter walk test in the two randomization groups

    Measured: 12 months

Secondary outcomes (9)
  1. Participants' adherence/retention to the intervention protocol and control groups

    Participants' adherence/retention to the intervention protocol

    Measured: 12 months

  2. Intercurrent illnesses rates

    Intercurrent illnesses rates in the two randomization groups

    Measured: 12 months

  3. Serious fall injuries

    Incident fall injuries occurred in the two randomization groups

    Measured: 12 months

  4. Hospitalizations and institutionalization rates

    Incidence of acute care hospitalizations and nursing home admissions in the two randomization groups

    Measured: 12 months

  5. Mortality

    Overall mortality rate in the two randomization groups

    Measured: 12 months

  6. Health-related quality of life

    Modifications of health-related quality of life in the two randomization groups

    Measured: 12 months

  7. Body composition modifications

    Body composition modifications (assessed using bioimpedance analysis) in the two randomization groups

    Measured: 12 months

  8. Modification of Pain

    Modification of pain symptoms in the two randomization groups

    Measured: 12 months

  9. Fatigue

    Modification of the fatigue symptom in the two randomization groups

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2014 (estimated)
  2. Study start16 Oct 2013
  3. Primary completionJan 2016
  4. Study completion27 Jan 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
210 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02082171
Sponsor's protocol ID
C12-55
Other IDs
2013-A00380-45
Acronym
MINDED
Status last verified
Aug 2021
First submitted
6 Mar 2014
Last updated
4 Sep 2025
Results posted
No
Data monitoring committee
Yes

Publications

  • Cesari M, Demougeot L, Boccalon H, Guyonnet S, Vellas B, Andrieu S. The Multidomain Intervention to preveNt disability in ElDers (MINDED) project: rationale and study design of a pilot study. Contemp Clin Trials. 2014 May;38(1):145-54. doi: 10.1016/j.cct.2014.04.006. Epub 2014 Apr 24.

    PubMed 24768939

Questions about this trial

What is this clinical trial studying?

A study testing Multidomain intervention in people with Physical Frailty and Physical Disability, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

400-meter walk test (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02082171, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in